Picture of Derwent London logo

DLN Derwent London News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedMid CapNeutral

REG - Derwent London PLC - Admission to Trading

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260410:nRSJ0599Aa&default-theme=true

RNS Number : 0599A  Derwent London PLC  10 April 2026

For immediate release

 

 

Derwent London plc

 ("Derwent London"/"the Company")

 

Admission to Trading

 

 

In accordance with the Financial Conduct Authority's Prospectus Rules:
Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, the
Company notifies the market that the following shares have been admitted to
trading pursuant to their allotment under the Derwent London Performance Share
Plan 2014 as follows:

 

 

 Issuer name:                                                                  Derwent London plc

 Issuer LEI:                                                                   213800BXKQ9KZNUR1M61
 Regulated market on which the shares have been admitted to trading:           London Stock Exchange (XLON)
 Description and type of financial instrument:                                 Ordinary shares of 5p in Derwent London plc

 Identification code:                                                          GB0002652740
 Number of shares issued and admitted to trading during period of return (new  6,193
 shares are fungible with existing shares)
 Total number of shares in issue and admitted to trading following issuance:   112,297,122
 Coverage of notification:                                                     10 March 2026 - 10 April 2026

 

 

Enquiries:

D A Lawler

Company Secretary

 

10 April 2026

 

020 7659 3000

www.derwentlondon.com (http://www.derwentlondon.com)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ADMGPUBWCUPQGAU



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Derwent London

See all news